Featured PGRN Investigators

Michelle Whirl-Carrillo, PhD is the Associate Director of PharmGKB and Senior Research Scientist in the Department of Genetics at Stanford University. She manages the team of scientific curators and developers at PharmGKB, and works with the Director to set priorities and direction for the project. She is interested in breaking down barriers to the routine clinical use of pharmacogenomics through education and raising awareness of the field. Her work includes finding new pharmacogenomics knowledge to incorporate into PharmGKB and developing criteria to assess that knowledge, including information curated from the literature and drug labels. She worked with the CPIC (Clinical Pharmacogenetics Implementation Consortium) leadership to help develop the standards used to score evidence and weigh dosing recommendations, and has co-authored several CPIC guidelines. She has worked on a variety of projects focused on standardizing representation of pharmacogenomics information. Currently, she is working with PharmGKB, CPIC and the ClinGen PGx working group to incorporate pharmacogenomics associations into ClinVar, an NCBI resource that catalogs genomic variation affecting human health.